Clinical Trials

Hematologic Diseases, Immune System Diseases, Neoplasms, Hematologic Neoplasms

NCT05969821 2026-03-23

CHIS

Not yet recruiting

5,000 enrolled

Phase 1/2 Not yet recruiting

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT07387354 2026-03-16

MDS

25 enrolled

Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT05032820 2026-03-05

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

Phase 2 Completed

40 enrolled 21 charts

Plasma cell

Hematologic Diseases, Multiple Myeloma

NCT06910969 2026-03-03

HORIZONS

Phase NA Recruiting

350 enrolled

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT03514017 2026-03-02

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia

Phase 2 Terminated

5 enrolled 11 charts

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04761770 2026-02-17

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

MyeloidOther hematologic neoplasm

33 enrolled

Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT05895994 2026-02-03

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Phase EARLY_PHASE1 Completed

2 enrolled

Phase 1 Not yet recruiting

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT07379125 2026-01-30

Therapeutic RSK1 Targeting in Myelofibrosis

18 enrolled

Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT03159702 2026-01-27

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Phase 2 Completed

43 enrolled 9 charts

Other hematologic neoplasmPlasma cell

Hematologic Diseases, Multiple Myeloma, Hematologic Neoplasms

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Phase 1/2 Active not recruiting

43 enrolled

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT04180059 2026-01-26

CTL-DP 01

Phase NA Enrolling by invitation

6 enrolled

Hematologic Diseases

NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

1,006 enrolled

GastrointestinalGenitourinary

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

NCT07364409 2026-01-23

ReSTORE

Phase NA Active not recruiting

5 enrolled

Azoospermia, Nonobstructive, Hematologic Diseases, Infertility, Male, Neoplasms

NCT01352520 2026-01-20

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

79 enrolled

DermatologicLymphoid

Hematologic Diseases, Lymphoma, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis, Lymphoma, Primary Cutaneous Anaplastic Large Cell

NCT04062266 2026-01-13

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

50 enrolled

Hematologic Diseases, Leukemia, Myeloid, Acute

NCT04640987 2026-01-08

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

22 enrolled

Hematologic Diseases

NCT04572815 2026-01-02

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Phase 2 Not yet recruiting

116 enrolled

Hematologic Diseases

NCT07303881 2025-12-26

JACKPOT22

16 enrolled

Thoracic

Hematologic Diseases, Lung Neoplasms, Neoplasm Metastasis

NCT00186147 2025-12-18

Bone Marrow Grafting for Leukemia and Lymphoma

Enrolling by invitation

9,999 enrolled

LymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma

NCT07257640 2025-12-10

IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia

20 enrolled

Hematologic Diseases, Neoplasms

NCT04167683 2025-12-08

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Active not recruiting

144 enrolled

Hematologic Diseases, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06559189 2025-11-28

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

53 enrolled

Lymphoid

Burkitt Lymphoma, Hematologic Diseases, Recurrence

NCT07200583 2025-11-18

PAIA-Haplo

Completed

50 enrolled

Hematologic Diseases, Hematologic Neoplasms

NCT06472089 2025-10-15

BMT-CARE

Phase NA Recruiting

800 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT03356171 2025-10-02

APACCHE

Phase NA Completed

80 enrolled

Hematologic Diseases, Motor Activity, Neoplasms

NCT06095752 2025-10-02

Multiple Myeloma Prognostic Indices

Completed

48 enrolled

Plasma cell

Hematologic Diseases, Multiple Myeloma

NCT06487247 2025-09-17

HEME Home Transfusion Program

Phase NA Recruiting

700 enrolled

Hematologic Diseases, Leukemia, Lymphoma, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT05827835 2025-08-13

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

Phase 1/2 Recruiting

30 enrolled

Hematologic Diseases, Neoplasms

NCT05150561 2025-08-11

Muscle Dysfunction in Patients With Haematological Diseases

Active not recruiting

216 enrolled